Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
4,693,697
-
Total 13F shares
-
830,388
-
Share change
-
+16,302
-
Total reported value
-
$517,000
-
Price per share
-
$0.62
-
Number of holders
-
12
-
Value change
-
-$35,415
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of KIORA PHARMACEUTICALS INC - Common Shares (KPRX) as of Q1 2022
As of 31 Mar 2022,
KIORA PHARMACEUTICALS INC - Common Shares (KPRX) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
830,388 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Ergoteles LLC, GOLDMAN SACHS GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Tower Research Capital LLC (TRC), and US BANCORP \DE\.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.